This site is intended for health professionals only

Monday 20 May 2019
Share |

Topic: Theatres and surgery

May 2, 2019
Clinical Fellow Ben Shelley is driving forward the chronic pain trial at the Golden Jubilee Hospital in Scotland
Researchers at the Golden Jubilee National Hospital in Scotland have recruited the first patients for a new trial which aims to reduce chronic pain following open lung surgery.
 
The first patients have been recruited and operated on within 24 hours of the TOPIC2 trial, which is funded by the National Institute for Health Research Health Technology Assessment Programme, starting at the National Hospital – the only Scottish centre participating in the UK multi centre trial.
 
December 17, 2018
The study results indicate the need for a personalised approach to delirium in the ICU
A population heath study from the Regenstrief Institute and Indiana University Center for Aging Research has determined that haloperidol, the drug most commonly used to treat delirium in hospital medical and surgical intensive care units (ICUs), did not benefit elective thoracic surgery ICU patients when given prophylactically, with the possible exception of those who have had surgery to remove their oesophagus.
 
The study results indicate the need for a personalised approach to delirium in the ICU.
 
December 3, 2018
The study recommends active surveillance to prevent over-treatment, suggesting that 36% of patients with a new diagnosis are candidates for active surveillance, 30% of whom will ultimately have treatment for progression
A new study has confirmed the effectiveness of Prostate-specific Antigen (PSA) screening in reducing prostate cancer mortality.
 
The retrospective cohort study of over 400,000 men, as published in Elsevier’s Urology® journal,1 set out to re-examine the value of PSA screening, to determine the optimal screening interval and the appropriate age groups to be screened. 
 
October 9, 2018
The 2015 Association of Anaesthetists and Great Britain and Ireland standards of monitoring during anaesthesia and recovery is a landmark guideline that builds upon previous recommendations
Increasing demands on the provision of anaesthetic services have been met with greater patient safety. While the primary determinant of anaesthetic safety is the presence of trained and experienced anaesthetists, human error remains unavoidable.1 Rather than prevent adverse incidents, patient monitoring may reduce the risk of harm by detecting and alerting the caregiver to a change in patient condition, thereby increasing the margin of safety.2-4
 
October 9, 2018
This article aims to explore the various modalities available for providing analgesia for major open abdominal surgery and the evidence surrounding their use, risks and benefits
October 9, 2018
Unexpected patient harm occurs more frequently than expected in the operating theatre. Learning to deal with these situations, as well as using available resources, might effectively prevent future harm as well as improve the quality of the attention provided during serious adverse events
Not all adverse events are necessarily severe, and thereby do not require an extensive institutional response. Severe adverse events are unexpected and undesirable situations that are related to death or great physical and/or psychological damage suffered by patients under medical attention. These events always require not only a strong institutional response,1 but also one that is immediate and helps to identify the underlying causes that lead to them. 
 
October 9, 2018
Stress immunity is an important personality trait of doctors, with a high representation seen in surgery. With one in five surgeons dropping out of training and 80% reporting burnout symptoms, methods to increase job satisfaction and reduce burnout are required
In surgery, we are all too quick to judge the psychology of our patients; however, understanding our own personality is essential to optimise our own performance. Our surgical decision-making requires the ability to judge the patient’s personality, while simultaneously understanding our own character and temperament, to allow a patient-centred consultation and consent for surgery. 
 

The psychological traits of a surgeon

May 17, 2018
A 70-year-old woman who was able to return home just three days after complex major surgery to cure her bladder cancer has thanked the NHS for saving her life

Jennifer Atkinson, 70, of Tickhill, South Yorkshire, underwent a radical cystectomy at the Royal Hallamshire Hospital in Sheffield, a 4.5 hour long operation to remove her bladder and womb.

She was one of a group of patients who were able to return home just three days after the surgery as a result of enhanced post-operative recovery procedures at the hospital’s urology department.

May 10, 2018
Both studies investigated links between postoperative delirium and particular biomarkers

Masimo has announced the use of Masimo technologies – O3® regional oximetry and SedLine® brain function monitoring – in two abstracts presented at the 2018 Annual Meeting of the International Anesthesia Research Society (IARS). Both studies investigated links between postoperative delirium and particular biomarkers.

May 10, 2018
Researchers investigated the utility of Masimo non-invasive and continuous haemoglobin in supporting and enhancing red blood cell transfusion best practices as part of post-operative patient blood management

Masimo has announced the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous haemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1

April 11, 2018
Continuous oxygenation and ventilation monitoring with upgradeable rainbow® parameters in a compact, standalone device

Masimo has announced the CE marking of the Rad-97™ Pulse CO-Oximeter® with integrated NomoLine™ capnography.

April 6, 2018
UniView aggregates and displays patient data from multiple devices to minimise clinician cognitive overload and maximise patient safety

Masimo has announced the release of UniView™, an integrated display of real-time data and alarms from multiple Masimo and third-party devices, designed to reduce clinician cognitive overload and improve patient safety. UniView promotes data sharing and team coordination among multiple clinicians.

March 13, 2018
SpHb showed excellent correlation with Lab-Hb in fluid responders, fluid non-responders, low-Pi, and high-Pi states

Masimo has announced the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous haemoglobin (SpHb®), referenced to an invasive laboratory haemoglobin (Lab-Hb) measurement, during acute bleeding and after fluid resuscitation.1

March 8, 2018
Masimo has announced the release of Replica™, an application for smart phones and tablets that works in conjunction with Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system

Replica allows clinicians to view continuous monitoring data for multiple patients, as well as view and respond to alarms and alerts, all from their smart phones, regardless of location.

February 22, 2018
Results show that non-invasively assessed PVi and dIVC were good predictors of fluid responsiveness after PLR in ICU patients on mechanical ventilation

February 8, 2018
Eve combines the power of Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry with a pre-ductal to post-ductal synchronisation algorithm designed to reduce calculation errors

Masimo has announced the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse CO-Oximeter®.

January 29, 2018
Like RD SET sensors, RD rainbow Lite SET sensors are designed to maximise patient comfort and optimise clinician workflow

Masimo has announced the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ (ORi™) and RPVi™, an improved PVi® that allows clinicians to assess fluid responsiveness noninvasively and continuously1 at a fraction of the cost of invasive methods, and at a fraction of the cost of rainbow® sensors.

January 29, 2018
Researchers at the UC Davis School of Medicine evaluated the potential clinical utility of Masimo Oxygen Reserve Index™ as an early warning of impending arterial haemoglobin desaturation in obese patients

Masimo has announced the findings of an abstract presented at the annual meeting of the Society for Technology in Anesthesia (STA) in Miami, Florida.

In the study, researchers at the UC Davis School of Medicine evaluated the potential clinical utility of Masimo Oxygen Reserve Index™ (ORi™) as an early warning of impending arterial haemoglobin desaturation in obese patients.1 This is the first published research investigating the utility of ORi in this particular population group.

November 2, 2017
RAM non-invasively and continuously measures respiration rate using an innovative adhesive sensor with an integrated acoustic transducer, such as Masimo's RAS-125c and now RAS-45, that is applied to the patient's neck area

Masimo has announced the full market release of RAS-45, an adhesive adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™). RAS-45 offers the same performance as the currently available RAS-125c sensor but in a smaller size, with more flexible adhesive.

November 2, 2017
BORN Project convenes public health stakeholders to highlight key program successes at three-year mark, reinforcing global call to action to support universal newborn pulse oximetry screening as a tool to significantly reduce newborn mortality and drive treatment infrastructure in low-resource settings

Masimo and the Newborn Foundation has announced that the BORN Project, their joint commitment to the United Nations’ Every Woman Every Child (EWEC) initiative, has now screened 52,000 newborns across 40 delivery sites in China for critical congenital heart disease (CCHD), pneumonia, and sepsis.

November 2, 2017
Trace is the first data visualisation and reporting software compatible with the full capabilities of the Masimo Root Patient Monitoring and Connectivity Platform

Masimo has announced the US release of Trace™, patient data visualisation and reporting software designed for Masimo Root® and Radical-7® monitors.

September 18, 2017
Utilisation of goal-directed fluid therapy protocols based on PVi may prevent excessive intraoperative infusion of fluids in laparoscopic bariatric surgery

Masimo has announced the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1

September 18, 2017
Patient SafetyNet, in conjunction with Masimo SET® pulse oximetry, enables continuous supplemental monitoring of active patients in post-surgical wards and can help save the lives of patients on opioids, among many other benefits

Masimo has announced that the Dubai Health Authority (DHA), the government organisation that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equipment and technology with the implementation of Masimo Patient SafetyNet™, a supplemental remote monitoring and clinician notification system, at two hospitals in Dubai.

September 18, 2017
SpHb showed accurate precision in both absolute values and trend values compared to LabHb measurement in trauma patients with low haemoglobin levels

Masimo has announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous hemoglobin measurement, in trauma patients with low haemoglobin levels.1